104. Amniofix as an Aid for the Esophagojejunal Anastamosis In Supercharged Pedicled Jejunum for Total Esophageal Reconstruction

PURPOSE: The supercharged pedicled jejunum has been shown to provide comparable or superior functional outcomes to other options for total esophageal reconstruction. Common complications following this procedure include anastomotic leaks and dehiscence. Amnio fix is a tissue allograft composed of dehydrated human amnion/chorion membrane (DHACM) which has been shown to upregulate basic fibroblast growth factor (FGF), granulocyte colony-stimulating factor, and placental grown factor by dermal fibroblasts, and aid in chronic wound treatment. No study to date has examined the potential therapeutic efficacy AmnioFix(AF) holds for preventing anastomotic complications METHODS: We conducted a retrospective chart review of patients who underwent supercharged pedicled jejunum flaps for total esophageal defects over a 16-year period at our institution, some of which received AF mesh as reinforcement around the esophagojejunal anastamotic site. RESULTS: A total of 37 patients this procedure, and 9(24.3%) had AF. Average age was 58.0±12.1 and BMI at the time of surgery was 24.3±4.9. Average length of hospital stay was 19.0±14.1 days. Post-operatively, AF patients had significantly less leaks at the esophagojejunal site (1 AF patient vs. 14 non-AF patients, p=0.03) and fistulas (0 AF patients, 6 non-AF patients, p=0.04). Patients with AF (8,88.9%) were significantly more likely to return to solid diets at last follow up than those who did not receive reinforcement(13, 35.1%). Usage of AmnioFix did not significantly impact operative time (455.0±19.1 minutes versus 478±15.7 minutes). Average ischemia time was 64±13.5 minutes. Three patients who initially did not have AmnioFix reinforcement required esophagojejunal revisions where AF was installed, and demonstrated no leaks, fistulas, or evidence of aspiration following AF use. CONCLUSION: Usage of AmnioFix mesh for esophago jejunal anastomosis in the setting of esophageal reconstruction with supercharged jejunal flap demonstrated significantly lower post-operative leaks, and fistulas without significantly extending operative time.

Authors

Institutions

Publication Details

Journal
Plastic & Reconstructive Surgery Global Open
Published
2025-04-24
DOI
https://doi.org/10.1097/01.gox.0001112364.59472.98
Primary Topic
Esophageal and GI Pathology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

104. Amniofix as an Aid for the Esophagojejunal Anastamosis In Supercharged Pedicled Jejunum for Total Esophageal Reconstruction

Dung Hoang Nguyen, Anita T. Mohan, Kassandra Carrion, Gordon K. Lee et al.
Plastic & Reconstructive Surgery Global Open
Esophageal and GI Pathology
article

104. Amniofix as an Aid for the Esophagojejunal Anastamosis In Supercharged Pedicled Jejunum for Total Esophageal Reconstruction

Dung Hoang Nguyen, Anita T. Mohan, Kassandra Carrion, Gordon K. Lee, George Nageeb
article en

Abstract

PURPOSE: The supercharged pedicled jejunum has been shown to provide comparable or superior functional outcomes to other options for total esophageal reconstruction. Common complications following this procedure include anastomotic leaks and dehiscence. Amnio fix is a tissue allograft composed of dehydrated human amnion/chorion membrane (DHACM) which has been shown to upregulate basic fibroblast growth factor (FGF), granulocyte colony-stimulating factor, and placental grown factor by dermal fibroblasts, and aid in chronic wound treatment. No study to date has examined the potential therapeutic efficacy AmnioFix(AF) holds for preventing anastomotic complications METHODS: We conducted a retrospective chart review of patients who underwent supercharged pedicled jejunum flaps for total esophageal defects over a 16-year period at our institution, some of which received AF mesh as reinforcement around the esophagojejunal anastamotic site. RESULTS: A total of 37 patients this procedure, and 9(24.3%) had AF. Average age was 58.0±12.1 and BMI at the time of surgery was 24.3±4.9. Average length of hospital stay was 19.0±14.1 days. Post-operatively, AF patients had significantly less leaks at the esophagojejunal site (1 AF patient vs. 14 non-AF patients, p=0.03) and fistulas (0 AF patients, 6 non-AF patients, p=0.04). Patients with AF (8,88.9%) were significantly more likely to return to solid diets at last follow up than those who did not receive reinforcement(13, 35.1%). Usage of AmnioFix did not significantly impact operative time (455.0±19.1 minutes versus 478±15.7 minutes). Average ischemia time was 64±13.5 minutes. Three patients who initially did not have AmnioFix reinforcement required esophagojejunal revisions where AF was installed, and demonstrated no leaks, fistulas, or evidence of aspiration following AF use. CONCLUSION: Usage of AmnioFix mesh for esophago jejunal anastomosis in the setting of esophageal reconstruction with supercharged jejunal flap demonstrated significantly lower post-operative leaks, and fistulas without significantly extending operative time.

Plastic & Reconstructive Surgery Global OpenVol. 13(S1)
Palo Alto University (US), University of California, Irvine (US), Stanford University (US)
Zero hunger
Openalex Percentile: Top 85%
Esophageal and GI Pathology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.